In summary, even though TN and HER2-positive tumors were reported to have the worst prognosis and Luminal A tumors the best, while Luminal B tumors were variable, intrinsic study limitations need to be kept in mind when considering the links between tumor sub-type and prognosis as several methodological flaws could have impacted on the results. This evidence concerns the gene ERBB2 and neoplasm.